Rep. Mike Honda, D-Calif., of the Silicon Valley is preparing to introduce legislation that will create a new division within the Food and Drug Administration to govern fast-developing healthcare applications, according to a report published by Kaiser Health News last week.

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

The Food and Drug Administration has approved a drug for treating a complication of a disease that results from vein blockages in the eye.

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

The Food and Drug Administration has approved a generic drug for motion sickness made by Mylan.

A subsidiary of Johnson & Johnson is hoping to gain Food and Drug Administration approval for a new formulation of one of its drugs.

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.